NCT00519688View on ClinicalTrials.gov

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Thalidomide

100 mg, BID

DRUG

Tegafur/Uracil

125 mg/m2, based on tegafur, BID

Trial Locations (1)

Unknown

Department of Oncology , National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00519688 - UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter